Located in Lund, Sweden, Zelmic focuses solely on developing topically administered drugs. With a small and dedicated team, they offer cost-effective and efficient services, providing expertise in product development, CMC documentation, analytical chemistry, performance testing, bioequivalence testing, and more. Zelmic aims to expand their offerings with the launch of an in-house manufacturing facility in 2022, providing additional CDMO services. Their track record in pharmaceutical product development makes them a valuable partner for organizations looking to achieve their goals and minimize risks.